A Study of LY4064809 [14C]-STX-478 in Healthy Male Participants
Clinical trial NCT06901336 · COMPLETED
Trial details
- NCT number
- NCT06901336
- Sponsor
- Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-20
- Primary completion
- 2025-05-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.